This topic contains a solution. Click here to go to the answer

Author Question: The primary factor that differentiates an open system from a closed system is _____. a. a closed ... (Read 151 times)

mckennatimberlake

  • Hero Member
  • *****
  • Posts: 559
The primary factor that differentiates an open system from a closed system is _____.
 
  a. a closed system is self-contained and isolated from interactions with its environment
  b. open systems sustain dynamic equilibrium whereas a closed system disintegrates into entropy
  c. open systems have a feedback loop and closed systems do not
  d. all of the above
  e. none of the above

Question 2

The LPC determines which behavior the leader should use.
 
  a. true
  b. false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cclemon1

  • Sr. Member
  • ****
  • Posts: 312
Answer to Question 1

d

Answer to Question 2

b;





 

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

Astigmatism is the most common vision problem. It may accompany nearsightedness or farsightedness. It is usually caused by an irregularly shaped cornea, but sometimes it is the result of an irregularly shaped lens. Either type can be corrected by eyeglasses, contact lenses, or refractive surgery.

Did you know?

When blood is exposed to air, it clots. Heparin allows the blood to come in direct contact with air without clotting.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library